Brief: Kuros Biosciences Announces Start Of Of Randomized Controlled Trial Of Magnetos In Spinal Fusion
June 12 (Reuters) - Kuros Biosciences AG KURN.S :
* KUROS BIOSCIENCES ANNOUNCES START OF OF RANDOMIZED
CONTROLLED
TRIAL OF MAGNETOS IN SPINAL FUSION
Source text for Eikon: ID:nTEN8ib80a
Further company coverage: KURN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kuros Biosciences AG
See all newsSwitzerland's Kuros Biosciences swing to H1 profit as revenue jumps
Brief: Kuros Biosciences H1 Gross Profit USD 79.965 Million
Europe Research Roundup: Avanza Bank, Forvia, Novonesis
Switzerland's Kuros Biosciences 2025 total medical device revenue rises, helped by MagnetOs growth
Brief: Kuros Biosciences FY Net Income USD 2.462 Million